A detailed history of Sequoia Financial Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Sequoia Financial Advisors, LLC holds 8,851 shares of EW stock, worth $579,563. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,851
Previous 11,546 23.34%
Holding current value
$579,563
Previous $1.1 Million 25.93%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$84.3 - $94.31 $227,188 - $254,165
-2,695 Reduced 23.34%
8,851 $817,000
Q1 2024

Apr 30, 2024

SELL
$72.54 - $95.56 $160,458 - $211,378
-2,212 Reduced 16.08%
11,546 $1.1 Million
Q4 2023

Jan 25, 2024

BUY
$61.71 - $77.76 $252,702 - $318,427
4,095 Added 42.38%
13,758 $1.05 Million
Q3 2023

Nov 08, 2023

SELL
$69.28 - $93.38 $256,336 - $345,506
-3,700 Reduced 27.69%
9,663 $669,000
Q2 2023

Aug 08, 2023

SELL
$81.41 - $94.33 $113,974 - $132,062
-1,400 Reduced 9.48%
13,363 $1.26 Million
Q1 2023

Apr 24, 2023

BUY
$74.26 - $84.51 $99,508 - $113,243
1,340 Added 9.98%
14,763 $1.22 Million
Q4 2022

Jan 17, 2023

BUY
$68.3 - $87.44 $358,370 - $458,797
5,247 Added 64.18%
13,423 $0
Q3 2022

Oct 26, 2022

SELL
$82.37 - $107.29 $39,619 - $51,606
-481 Reduced 5.56%
8,176 $676,000
Q2 2022

Jul 22, 2022

SELL
$86.5 - $128.27 $45,326 - $67,213
-524 Reduced 5.71%
8,657 $823,000
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $95,944 - $120,767
941 Added 11.42%
9,181 $1.08 Million
Q4 2021

Feb 11, 2022

BUY
$106.37 - $130.68 $876,488 - $1.08 Million
8,240 New
8,240 $1.07 Million
Q3 2021

Oct 26, 2021

SELL
$102.91 - $122.75 $791,789 - $944,438
-7,694 Closed
0 $0
Q2 2021

Jul 27, 2021

BUY
$83.84 - $104.76 $80,234 - $100,255
957 Added 14.21%
7,694 $797,000
Q1 2021

May 14, 2021

BUY
$78.68 - $90.67 $28,088 - $32,369
357 Added 5.6%
6,737 $563,000
Q4 2020

Feb 12, 2021

BUY
$71.69 - $91.23 $430 - $547
6 Added 0.09%
6,380 $582,000
Q3 2020

Oct 23, 2020

SELL
$67.19 - $87.44 $6,450 - $8,394
-96 Reduced 1.48%
6,374 $509,000
Q2 2020

Aug 25, 2020

BUY
$57.54 - $76.95 $372,283 - $497,866
6,470 New
6,470 $447,000
Q2 2020

Aug 11, 2020

SELL
$57.54 - $76.95 $126,300 - $168,905
-2,195 Closed
0 $447,000
Q1 2020

May 11, 2020

SELL
$52.41 - $81.0 $838 - $1,296
-16 Reduced 0.72%
2,195 $414,000
Q4 2019

Feb 13, 2020

BUY
$71.7 - $82.09 $10,253 - $11,738
143 Added 6.91%
2,211 $516,000
Q3 2019

Oct 22, 2019

BUY
$61.55 - $75.43 $6,031 - $7,392
98 Added 4.97%
2,068 $455,000
Q2 2019

Jul 31, 2019

BUY
$55.74 - $64.41 $32,217 - $37,228
578 Added 41.52%
1,970 $364,000
Q1 2019

May 13, 2019

BUY
$47.89 - $64.05 $66,662 - $89,157
1,392 New
1,392 $266,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Sequoia Financial Advisors, LLC Portfolio

Follow Sequoia Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sequoia Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sequoia Financial Advisors, LLC with notifications on news.